http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106996975-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106996975-B |
| titleOfInvention | Circulating tumor cell albumen parting kit |
| abstract | The present invention relates to a kind of circulating tumor cell albumen parting kits, include: for the capture antibody of different CTCs protein markers, the CTCs protein marker includes epithelial cell protein marker, interstitial cell protein marker；The epithelial cell protein marker is selected from: EPCAM, E-cadherin, KRT5, KRT7, KRT8, KRT16, KRT17, KRT18, KRT19, KRT20；The interstitial cell protein marker is selected from: N-cadherin, vimentin, fibronectin, MMP2, MMP3, MMP9, AKT2, ZEB1, FOXC1, FOXC2, SNAI1, SNAI2, SERPINE1；It further include the labelled antibody for different CTCs protein markers, the selection of protein marker of the present invention, other than being able to achieve the detection of single protein marker, also it is used together with other protein markers, so as to most comprehensively detect circulating tumor cell, and its cell type is distinguished, it solves and false negative result is caused due to the difference of certain protein marker expressions between circulating tumor cell individual. |
| priorityDate | 2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.